Clinical Experience With Insulin Resistance, Diabetic Ketoacidosis, and Type 2 Diabetes Mellitus in Patients Treated With Atypical Antipsychotic Agents
J Clin Psychiatry 2001;62(suppl 27):10-14
© Copyright 2017 Physicians Postgraduate Press, Inc.
Access to this article is available to valid users
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Register: If you do not have one already, register for a free account.
Numerous reports have associated atypical antipsychotic agents with hyperglycemia, diabetes
mellitus, and diabetic ketoacidosis. Although the mechanisms are poorly understood, clinical experience
suggests that these adverse effects are major areas of concern and require attention by the psychiatric
team and primary care clinicians. This article discusses my clinical experience with glucose
metabolism impairment related to treatment with antipsychotic medications.